Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Engineered T cells kept leukemia from returning in 12 high-risk patients.
Experts discuss rapid changes in cancer treatment and in the management of infections that can accompany these therapies.
As an eligibility barrier cracks, a lung cancer patient gets a new lease on life.
A first-of-its-kind rapid autopsy program helps reveal the deadly disease’s potential vulnerabilities.
The first unequivocal proof in humans of immune cells’ cancer-curing power laid the groundwork for cancer immunotherapy.
Seven takeaways from community symposium highlighting recent advances in prevention, screening and treatment
New study tests ability of natural language processing to search lung cancer patients’ records for treatable mutations.
High-dose radiation, younger age increase risk of developing subsequent cancer, new study finds
Nancy Davidson, MD, on improving outcomes for women with breast, lung and colorectal cancer
‘To have your life-threatening cancer cured, and then to die of not being able to breathe? It’s devastating.’
The CASSINI Trial could inform new guidelines for diagnosing, preventing and treating cancer patients at high risk of developing blood clots
‘Patients are willing to participate in trials if they’re offered one.’
David MacPherson, PhD, discusses the state of SCLC research, how his lab is tackling the disease and what makes him excited for the future.
Once unheard-of survival rates seen among patients with advanced Merkel cell carcinoma.
Study reveals how blood vessels in the bone marrow protect dormant tumor cells, suggests a way to kill them in their sleep.
Loosening strict comorbidity criteria would open trials to thousands of previously ineligible patients.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.